100 people globally use brain-computer interfaces in clinical trials. Scaling up commercially is on the horizon

brain implant neuralink wide e e aaae e dffe f ad cab a a s c
Credit: Neuralink

Implanted BCIs [brain-computer interfaces] are electrodes put in paralyzed people’s brains so they can use imagined movements to send commands from their neurons through a wire, or via radio, to a computer. In this way, they can control a computer cursor or, in few cases, produce speech.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.
[A] small group of companies … are actively recruiting volunteers to try BCIs in clinical trials. They are Neuralink, backed by the world’s richest person, Elon Musk; New York–based Synchron; and China’s Neuracle Neuroscience. … [T]he first time a person controlled a computer cursor from a brain implant was in 1998. That was followed by a slow drip-drip of tests in which university researchers would find a single volunteer, install an implant, and carry out studies for months or years.

“In the next five to 10 years, it’s either going to translate into a product or it’ll still stay in research,” says [Michelle Patrick-Krueger, a research scientist who carried out a detailed survey of BCI trials with neuroengineer Jose Luis Contreras-Vidal at the University of Houston. “I do feel very confident there will be a breakout.”

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
viva-la-vida-watermelons
Misinformation and climate change are endangering summer watermelons
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
ChatGPT-Image-Mar-27-2026-11_27_05-AM
The myths of “process”: What science says about the “dangers’ of synthetic products and ultra-processed foods
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Drinking lots of water can help reduce the effects of aging
Nanoplastics in drinking water: MAHA activists forge science-based bipartisan coalition 
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.